期刊文献+

来氟米特对糖尿病大鼠肾组织中P-选择素表达的影响 被引量:5

The Effect of Leflunomide on Renal Expression of P-selectin mRNA in Diabetic Rats
下载PDF
导出
摘要 目的探讨P-选择素在糖尿病大鼠肾组织中的表达及来氟米特对其影响。方法高糖高脂饮食联合小剂量腹腔注射链脲佐菌素(streptozotocin,STZ)建立2型糖尿病动物模型。随机分为糖尿病组(B组)和来氟米特干预组(C组),另设鼠龄匹配的正常对照组(A组)。第8、9、12、16周,监测各组血糖(FBG)、糖化血红蛋白A1(HbA1c)、血脂、血肌酐(Scr)、尿素氮(BUN)、胰岛素(Insulin)及24小时尿蛋白定量。第9、16周各组随机处死6只大鼠,测量肾重指数。另外观察肾脏病理情况。用半定量RT-PCR方法检测肾皮质P-选择素(P-selectin)mRNA表达水平。结果大鼠肾脏病理符合2型糖尿病肾病的改变。与A组相比,第16周时B组血肌酐、尿素氮明显升高(P<0.01),24小时尿蛋白定量自糖尿病成模后即开始高于对照组(P<0.05),并于12、16周时仍持续增加(P<0.01,P<0.01)。与B组相比,C组大鼠BUN和Scr第16周时降低,差异有统计学意义(P<0.05,P<0.01),24小时尿蛋白定量12、16周时较B组降低(P<0.05,P<0.01)。糖尿病大鼠肾组织中P-selectin表达明显高于对照组(P<0.01),来氟米特干预后其表达降低(P<0.05)。结论来氟米特可能通过抑制糖尿病大鼠肾组织中P-选择素的表达发挥对肾脏的保护作用。 Objective To explore the expressions of P-selectin mRNA in the renal tissue of diabetic rats and the effects of Leflunomide.Methods The model of type 2 diabetes mellitus(DM) was set up by feeding high-glucose and high-fat diet and by injecting STZ into peritoneal cavity of rat.The diabetic rats were randomly divided into DM group(group B) and Leflunomide treated group(group C).The age-matched rats were set as controls(group A).Blood glucose,HbA1c,cholesterol,triglyceride,Scr,BUN,insulin and 24-hour urinary protein excretion were detected at 8,9,12 and 16 weeks respectively.Six rats were randomly sacrificed at 9 and 16 weeks in every group.Kidney index of rats were measured.Moreover,the renal pathological changes were observed.The expressions of P-selectin mRNA in the renal cortex were detected by semi-quantitative RT-PCR.Results Some pathological characteristics of diabetic nephropathy exist in type 2 diabetic rats.Compared with group A,Scr,BUN were significantly increased in group B at the end of 16th week(P0.01),while 24-hour urinary protein excretion was increased when the animal model of diabetes was established successfully(P0.05)and kept increasing at the end of 12th and 16th(P0.01,P0.01).Compared with group B,Scr,BUN in group C were decreased(P0.05,P0.01)at the end of 16th,24-hour urinary protein excretion was decreased at the end of 12th and 16th(P0.05,P0.01).Compared with the controls,the expressions of P-selectin mRNA in the renal tissue of diabetic rats were significantly increased(P0.01),while the expressions were decreased in Leflunomide treated group in compare with DM group(P0.05).Conclusion Leflunomide can protect the kidney in diabetic rats by inhibiting the expressions of P-selectin in renal tissue.
出处 《中国实验诊断学》 北大核心 2010年第5期654-659,共6页 Chinese Journal of Laboratory Diagnosis
关键词 糖尿病肾病 P-选择素 来氟米特 大鼠 Diabetic nephropathy P-selectin Leflunomide rat
  • 相关文献

参考文献16

  • 1Lei F,Carolyn M,Allan S,et al.Chronic vaFd2ular inflammation in patients with type 2 diabetes[J].Diabetes Care,2005,28(2):379.
  • 2Khamaisi M,Bieke F.The emerging role of VEGF indiabetie kidney disease[J].J Nephrol Dial Transplant,2003,18(8):1427.
  • 3Springer TA.Traffic signals for lymphocyte recirculation and leukocyte emigration:The multistep paradigm[J].Cell,1994,76(2):301.
  • 4魏林,王海燕,章友康,邹万忠,鄂洁.细胞外基质在人系膜增生性肾小球肾炎病变中的变化[J].中华病理学杂志,1994,23(1):7-9. 被引量:14
  • 5Danda RS,Habiba NM,Rincon-Choles H,et al Kidney involvement in a nongenetic rat model of type 2 diabetes[J].J Kidney International,2005,68(6):2562.
  • 6周迎生,高妍,李斌,刘冬戈,迟家敏,王抒,黎健.高脂喂养联合链脲佐菌素注射的糖尿病大鼠模型特征[J].中国实验动物学报,2005,13(3):154-158. 被引量:122
  • 7Hafner SM,Gonzalez C,Miettinen H,et al.A prospective analysis of the Homa model J.The Mexico city diabetes study[J].Diabetes Care,1996,19(10):1138.
  • 8Nauyen D,Ping F,Mu W,et al.Macrophage accumulation in human progressive diabetic nephropathy[J].Nephrology (Carlton).2006,11 (3):226-231.
  • 9Vestwebber D.Mechanisms that regulate the function of the selectins and their ligands[J].Physiol Rev,1999,79:181.
  • 10BoothG,StalkerYJ,LeferAM,et al.Mechanisms of amelioration of glucose-induced endothelial dysfunction following inhibition of protein kinase C in vivo[J].Diabetes,2002,51:1556.

二级参考文献42

  • 1Tuttle KR. Linking metabolism and immunology : diabetic nephropathy is an inflammatory disease. J Am Soc Nephrol, 2005,16(6):1537-1538.
  • 2Dandona P,Aljada A,Chaudhuri A,et al. Metabolic syndrome a comprehensive perpective based on interaction between obesity diabetes and inflammation. Circulation, 2005,111(11):1448-1454.
  • 3Wolf G, Ritz E. Combination therapy with ACE inhibitors and angiotensin II receptor blockers to halt progression of chronic renal disease:Pathophysiology and indications. Kidney Int,2005,67: 799-812.
  • 4Ruggenenti P. Angiotensin-converting enzyme inhibition and angiotensin 11 antagonism in nondiabetic chronic nephropathies. Semin Nephrol, 2004,24(2):158-167.
  • 5Xu X, Shen J, Mall JW, et al. In vitro and vivo antitumor activity of a novel immunomodulatory drug, leflunomide:mechanisms of action. Biochem Pharmacol, 1999,58(9): 1405-1413.
  • 6Manna SK,Arrarwal BB. Immunosuppressive leflunomide met abolite (A771726) blocks TNF-dependent nuclear factor-kappa B activation and gene expression. J immunol, 1999,162 (4): 2095 -2102.
  • 7Urushibara M, Takayanagi H, Koga T, et al. The antirheumatic drug leflunomide inhibits osteoclastogenesis by interfering with receptor activator NF-kappa B ligand-stimulated induction of nuclear factor activated T cells cl. Arthritis Rheum,2004,50(3): 794-804.
  • 8章友康,中华肾脏病杂志,1992年,8卷,1期,35页
  • 9胡瑞德,中华病理学杂志,1985年,14卷,2期,149页
  • 10Jonas JC, Sharma A, Hasenkamp W, et al. Chronic hyperglycemia triggers loss of pancreatic β cell differentiation in an animal model of diabetes [J]. J Biol Chem. 1999, 274 (20): 14112 - 14121.

共引文献167

同被引文献43

  • 1付宇,王丹,石鹏,赵武,林为民,袁莉.来氟米特治疗糖尿病肾病大量蛋白尿20例临床分析[J].临床内科杂志,2007,24(7):470-471. 被引量:14
  • 2迟加敏.实用糖尿病学[M].第3版.北京:人民卫生出版社,2009:118-121,511-520.
  • 3Lu HE,Jian CH,Chen SF,et al.Hypoglycaemic effects of fermented mycelium of Paecilomyces farinosus(G30801)on high-fat fed rats with streptozotocin-induced diabetes[J].Indian J Med Res,2010,131:696-701.
  • 4Madkor HR,Mansour SW,Ramadan G.Modulatory effects of garlic,ginger,turmeric and their mixture on hyperglycaemia,dyslipidaemia and oxidative stress in streptozotocin-nicotinamide diabetic rats[J].Br J Nutr,2011,105(8):1210-1217.
  • 5Arya A,Yadav HN,Sharma PL.Involvement of vascular endothelial nitric oxide synthase in development of experimental diabetic nephropathy in rats[J].Mol Cell Biochem,2011,354(1-2):57-66.
  • 6宁尚侠,李桃荣.杏丁注射液联合厄贝沙坦治疗2型糖尿病早期肾病41例[J].临床医药,2008,3(17):41-42.
  • 7Kim SH,Jang YW,Hwang P,et al.The reno-protective effect of a phosphoinositide3-kinase inhibitor wortmannin on streptozotocin-in-duced proteinuric renal disease rats[J].Exp Mol Med,2012,44(1):45-51.
  • 8Nishiyama A,Kobori H,Konishi Y,et al.Mineralocorticoid re ceptor blockade enhances the antiproteinuric effect of an angiotensin II blocker through inhibiting podocyte injury in type2diabetic rats[J].J Pharmacol Exp Ther,2010,332(3):1072-1080.
  • 9Pilmore HL.Review:metformin:potential benefits and use in chronic kidney disease[J].Nephrology(Carlton),2010,15(4):412-418.
  • 10Alhaider AA,Korashy HM,Sayed-Ahmed MM,et al.Metformin at-tenuates streptozotocin-induced diabetic nephropathy in rats through modulation of oxidative stress genes expression[J].Chem Biol In-teract,2011,192(3):233-242.

引证文献5

二级引证文献27

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部